OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients
Clement Lo, Tadashi Toyama, Megumi Oshima, et al.
Cochrane library (2020) Vol. 2020, Iss. 8
Open Access | Times Cited: 22

Showing 22 citing articles:

American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update
Lawrence Blonde, Guillermo E. Umpierrez, Sarah Reddy, et al.
Endocrine Practice (2022) Vol. 28, Iss. 10, pp. 923-1049
Open Access | Times Cited: 315

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025
Nuha A. ElSayed, Rozalina G. McCoy, Grazia Aleppo, et al.
Diabetes Care (2024) Vol. 48, Iss. Supplement_1, pp. S181-S206
Closed Access | Times Cited: 56

Utilization Trends of Glucose-Lowering Medications Among Adult Kidney Transplant Recipients with Type 2 Diabetes in the United States
Panupong Hansrivijit, Helen Tesfaye, Deborah J. Wexler, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 651-651
Open Access | Times Cited: 1

Efficacy and Safety of SGLT-2 Inhibitors for Treatment of Diabetes Mellitus among Kidney Transplant Patients: A Systematic Review and Meta-Analysis
Api Chewcharat, Narut Prasitlumkum, Charat Thongprayoon, et al.
Medical Sciences (2020) Vol. 8, Iss. 4, pp. 47-47
Open Access | Times Cited: 34

Use of sodium-glucose co-transporter 2 inhibitors in solid organ transplant recipients with pre-existing type 2 or post-transplantation diabetes mellitus: A systematic review
Yolanda C. Lin, Merisa Mok, Jennifer Harrison, et al.
Transplantation Reviews (2022) Vol. 37, Iss. 1, pp. 100729-100729
Closed Access | Times Cited: 14

Early post-transplant hyperglycemia and post-transplant diabetes mellitus following heart transplantation
William Kuang, Lisa M. Raven, Christopher A. Muir
Expert Review of Endocrinology & Metabolism (2024) Vol. 19, Iss. 2, pp. 129-140
Closed Access | Times Cited: 2

Anaesthetic Approach to Enhanced Recovery after Surgery for Kidney Transplantation: A Narrative Review
Slawomir Jaszczuk, Shweta Natarajan, Vassilios Papalois
Journal of Clinical Medicine (2022) Vol. 11, Iss. 12, pp. 3435-3435
Open Access | Times Cited: 11

Glucagon‐like peptide‐1 receptor agonists and sodium‐glucose cotransporter 2 inhibitors for diabetes after solid organ transplantation
Lale A. Ertuğlu, Esteban Porrini, Mads Hornum, et al.
Transplant International (2021) Vol. 34, Iss. 8, pp. 1341-1359
Closed Access | Times Cited: 15

Recent advances in new-onset diabetes mellitus after kidney transplantation
Tess Montada-Atin, G. V. Ramesh Prasad
World Journal of Diabetes (2021) Vol. 12, Iss. 5, pp. 541-555
Open Access | Times Cited: 15

Topical Glucocorticoid Use and the Risk of Posttransplant Diabetes
Simon Bøtker, Henrik Birn, Lara Aygen Øzbay
Case Reports in Endocrinology (2023) Vol. 2023, pp. 1-5
Open Access | Times Cited: 4

Comparing survival outcomes for kidney transplant recipients with pre‐existing diabetes versus those who develop post‐transplantation diabetes
Azm Hussain, Alice Culliford, Nuvreen Phagura, et al.
Diabetic Medicine (2021) Vol. 39, Iss. 2
Closed Access | Times Cited: 6

Novel Drugs for the Management of Diabetes Kidney Transplant Patients: A Literature Review
Nancy Daniela Valencia-Morales, Beatriz Rodríguez-Cubillo, Rómulo Katsu Loayza-López, et al.
Life (2023) Vol. 13, Iss. 6, pp. 1265-1265
Open Access | Times Cited: 2

Diabetes medication following heart transplantation: a focus on novel cardioprotective therapies—a joint review from endocrinologists and cardiologists
Lisa M. Raven, Christopher A. Muir, Peter S. Macdonald, et al.
Acta Diabetologica (2022) Vol. 60, Iss. 4, pp. 471-480
Closed Access | Times Cited: 4

Insulin and its analogues– what are they for? (pros and cons)
Zafer Güney
Trends in Diabetes and Metabolism (2019) Vol. 2, Iss. 2
Open Access | Times Cited: 5

Les inhibiteurs du SGLT2 : une nouvelle ère pour nos patients
Jean‐Michel Halimi
Néphrologie & Thérapeutique (2021) Vol. 17, Iss. 3, pp. 143-148
Closed Access | Times Cited: 4

Uso de inibidores do cotransportador sódio-glicose 2 e sua relação com infecções geniturinárias
Daniel Faria Pedrosa, Danilo Vilela Vilhena, Altielly Montes Machado, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 1, pp. 2875-2888
Open Access

Cardiovascular Disease and Metabolic Complications after Kidney Transplantation
Chien-Jung Lin, Krista L. Lentine, Adnan Sharif
Oxford University Press eBooks (2024), pp. 134-149
Closed Access

Dipeptidyl peptidase‐4 inhibitor and insulin combination treatment in type 2 diabetes and chronic kidney disease: A meta‐analysis
Xianling Zhou, Heng Shi, Shiping Zhu, et al.
Journal of Diabetes Investigation (2021) Vol. 13, Iss. 3, pp. 468-477
Open Access | Times Cited: 2

Use of Sodium-Glucose Cotransporter-2 Inhibitor for Diabetes Management in Patients Following Kidney Transplantation
Erica F. Crannage, Katherine L. Nguyen, Morgan D. Ellebrecht, et al.
Journal of Pharmacy Technology (2023) Vol. 39, Iss. 3, pp. 147-155
Open Access

Page 1

Scroll to top